The following tables present information regarding the Company’s outstanding borrowings at June 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | | | | ($ in thousands) | | | | | | | | | | Description | | Due date | | Call Feature | | Balance | | Interest Rate | | FHLB Principal Reducing Credit | | 6/26/2028 to 12/20/2028 | | None | | $ | 728 | | | 0.00% to 1.00% fixed | | Trust Preferred Securities | | 1/23/2034 | | Quarterly by Company | | 10,310 | | | 6.58% at 6/30/26 adjustable rate 3 month CME Term SOFR + 2.91% | | Trust Preferred Securities | | 1/23/2034 | | Quarterly by Company | | 10,310 | | | 6.68% at 6/30/26 adjustable rate 3 month CME Term SOFR + 3.01% | | Trust Preferred Securities | | 9/20/2034 | | Quarterly by Company | | 12,372 | | | 6.11% at 6/30/26 adjustable rate 3 month CME Term SOFR + 2.41% | | Trust Preferred Securities | | 1/7/2035 | | Quarterly by Company | | 10,310 | | | 5.93% at 6/30/26 adjustable rate 3 month CME Term SOFR + 2.00% | | Trust Preferred Securities | | 6/15/2036 | | Quarterly by Company | | 25,774 | | | 5.33% at 6/30/26 adjustable rate 3 month CME Term SOFR + 1.65% | | Trust Preferred Securities | | 6/23/2036 | | Quarterly by Company | | 8,248 | | | 5.81% at 6/30/26 adjustable rate 3 month CME Term SOFR + 2.11% | Total borrowings / weighted average rate as of June 30, 2026 | | 78,052 | | | 5.88% | | Unamortized discount on acquired borrowings | | | | (3,335) | | | | | Total borrowings | | | | | | $ | 74,717 | | | |
The following tables present information regarding the Company’s outstanding borrowings at December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | ($ in thousands) | | | | | | | | | | Description | | Due date | | Call Feature | | Balance | | Interest Rate | | FHLB Principal Reducing Credit | | 6/26/2028 to 12/20/2028 | | None | | $ | 753 | | | 0.00% to 1.00% fixed | | Trust Preferred Securities | | 1/23/2034 | | Quarterly by Company | | 10,310 | | | 6.75% at 12/31/25 adjustable rate 3 month CME Term SOFR + 2.91% | | Trust Preferred Securities | | 1/23/2034 | | Quarterly by Company | | 10,310 | | | 6.85% at 12/31/25 adjustable rate 3 month CME Term SOFR + 3.01% | | Trust Preferred Securities | | 9/20/2034 | | Quarterly by Company | | 12,372 | | | 6.11% at 12/31/25 adjustable rate 3 month CME Term SOFR + 2.41% | | Trust Preferred Securities | | 1/7/2035 | | Quarterly by Company | | 10,310 | | | 6.17% at 12/31/25 adjustable rate 3 month CME Term SOFR + 2.00% | | Trust Preferred Securities | | 6/15/2036 | | Quarterly by Company | | 25,774 | | | 5.37% at 12/31/25 adjustable rate 3 month CME Term SOFR + 1.65% | | Trust Preferred Securities | | 6/23/2036 | | Quarterly by Company | | 8,248 | | | 5.80% at 12/31/25 adjustable rate 3 month CME Term SOFR + 2.11% | Total borrowings / weighted average rate as of December 31, 2025 | | 78,077 | | | 5.97% | | Unamortized discount on acquired borrowings | | | | (3,508) | | | | | Total borrowings | | | | | | $ | 74,569 | | | |
|